Mirae Asset Global Etfs Holdings Ltd. Travere Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 40,465 shares of TVTX stock, worth $853,811. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,465
Previous 44,284
8.62%
Holding current value
$853,811
Previous $364,000
55.49%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TVTX
# of Institutions
199Shares Held
85.2MCall Options Held
776KPut Options Held
912K-
Armistice Capital, LLC New York, NY7.65MShares$161 Million1.78% of portfolio
-
Black Rock Inc. New York, NY7.64MShares$161 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.9MShares$146 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.68MShares$98.8 Million2.23% of portfolio
-
Woodline Partners LP San Francisco, CA4.34MShares$91.6 Million0.55% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.35B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...